Aurobindo's product is already filed with the Drugs Controller General of India (DCGI) and is expected to be approved soon
Lupin actively contributes to alleviating the burden of COPD for patients across the nation
CiplaMed 2.0 leverages advanced analytics and automation
Combination creates an integrated provider of drug development and regulatory consulting services serving a complementary client base
The survey findings for Delhi-NCR revealed that speech sound disorders exhibit higher prevalence rates in the 6-12 years age group
ELREXFIO’s label contains a boxed warning for cytokine release syndrome and neurologic toxicity
Exor’s investment in Philips will not result in any share dilution and has been carried out by way of on-market share purchases
Ryan has nearly 20 years of global legal and IP expertise in the pharmaceutical industry
Newcastle University’s Dr Srikanth Ramaswamy has been announced as one of six new Fellows selected for the 2023 Lister prize
Continuous learning is not just an option but a responsibility that every healthcare professional must shoulder
Subscribe To Our Newsletter & Stay Updated
